MPMichal Pazdernik

Michal Pazdernik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michal Pazdernik has a total of 267 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical characteristics, management, and predictors of mortality: results from the national prospective cardiogenic shock registry (CZECH-SHOCK)

    by Michal Pazdernik, Petr Ostadal, Jiri Seiner, Jan Pudil, Anna Chaloupka, Martin Novak, Eva Lichnerova, Radek Pelouch, Dagmar Vondrakova, Aneta Dvorakova, et al.

    Aims: Only limited epidemiological data exist from national or international prospective multicentre registries covering the whole spectrum of cardiogenic shock (CS) aetiologies. Methods and results: A national prospective multicentre observational study, CZECH-SHOCK, was conducted in 15 main tertiary care centres in Czechia over a 12 month period from March 2023 to February 2024. A total of 418 patients with a median age of 70 (interquartile range 59–76) years were enrolled. The majority of patients was males (69.6%). A newly developed heart failure was observed in 76.8% patients, and acute myocardial infarction complicated by CS was the most frequent cause of a CS episode (56.7%). Mechanical circulatory support devices were utilized in 28.2% of cases. A 30 day mortality was 39.5%. In a multivariate analysis, six independent factors were associated with a higher 30 day mortality: age [odds ratio (OR) per 10-year increase: 1.78, 95% confidence interval (CI): 1.45–2.19], history of coronary artery disease (OR: 2.38, 95% CI: 1.41–4.30), history of chronic obstructive pulmonary disease (OR: 2.58, 95% CI: 1.27–5.25), Society for Cardiovascular Angiography and Interventions class on admission (OR per one class increase: 1.64, 95% CI: 1.27–2.11), renal replacement therapy during in-hospital stay (OR: 2.46, 95% CI: 1.32–4.59), and new mechanical ventilation after admission (OR: 4.58, 95% CI: 2.50–8.39). Conclusion: Acute myocardial infarction complicated by CS still represents the most frequent cause of CS episodes. The in-hospital mortality of patients with CS remains high, despite frequent utilization of haemodynamic support and organ replacement therapies.


  • Open Access

    Prague ICU: free educational platform in the field of acute cardiovascular care

    by Michal Pazdernik

    The landscape of medical education is evolving rapidly, adapting to the digital age. Prague ICU represents a significant leap in this evolution, specifically tailored for those involved in acute cardiovascular care. This online platform offers an extensive range of educational materials, from video tutorials to interactive clinical cases, making it a unique resource for medical professionals globally.

  • Top Cited Papers

    2023 ESC Guidelines for the management of endocarditis

    by Victoria Delgado, Nina Ajmone Marsan, Suzanne de Waha, Nikolaos Bonaros, Margarita Brida, Haran Burri, Stefano Caselli, Torsten Doenst, Stephane Ederhy, Paola Anna Erba, et al.


  • Role of genetics in the development of cardiac allograft vasculopathy

    by Lucie Mayerova, Anna Chaloupka, Peter Wohlfahrt, Jaroslav Alois Hubacek, Helena Bedanova, Zhi Chen, Josef Kautzner, Vojtech Melenovsky, Ivan Malek, Ales Tomasek, et al.

    Role of genetics in the development of cardiac allograft vasculopathy


  • Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

    by Michal Pazdernik, Bernard Iung, Bulent Mutlu, François Alla, Robert Riezebos, William Kong, Maria Carmo Pereira Nunes, Luc Pierard, Ilija Srdanovic, Hirotsugu Yamada, et al.

  • Open Access

    Psychological burden of the COVID-19 pandemic 6 months after the outbreak — the voice of the young doctors’ generation: An international survey

    by Katarzyna Czerwińska-Jelonkiewicz, Anna Beneria, Jordi Bañeras, Przemysław Kwasiborski, Poonam Velagapudi, Nkechinyere Ijioma, Maria Trêpa, Chala Fekadu, Christophe Vandenbriele, Maria Stratinaki, et al.


  • Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

    by Michal Pazdernik, Bernard Iung, Bulent Mutlu, François Alla, Robert Riezebos, William Kong, Maria Carmo Pereira Nunes, Luc Pierard, Ilija Srdanovic, Hirotsugu Yamada, et al.

    Purpose High mortality and a limited performance of valvular surgery are typical features of infective endocarditis (IE) in octogenarians, even though surgical treatment is a major determinant of a successful outcome in IE. Methods Data from the prospective multicentre ESC EORP EURO-ENDO registry were used to assess the prognostic role of valvular surgery depending on age. Results As compared to < 80 yo patients, ≥ 80 yo had lower rates of theoretical indication for valvular surgery (49.1% vs. 60.3%, p < 0.001), of surgery performed (37.0% vs. 75.5%, p < 0.001), and a higher in-hospital (25.9% vs. 15.8%, p < 0.001) and 1-year mortality (41.3% vs. 22.2%, p < 0.001). By multivariable analysis, age per se was not predictive of 1-year mortality, but lack of surgical procedures when indicated was strongly predictive (HR 2.98 [2.43–3.66]). By propensity analysis, 304 ≥ 80 yo were matched to 608 < 80 yo patients. Propensity analysis confirmed the lower rate of indication for valvular surgery (51.3% vs. 57.2%, p = 0.031) and of surgery performed (35.3% vs. 68.4%, p < 0.0001) in ≥ 80 yo. Overall mortality remained higher in ≥ 80 yo (in-hospital: HR 1.50[1.06–2.13], p = 0.0210; 1-yr: HR 1.58[1.21–2.05], p = 0.0006), but was not different from that of < 80 yo among those who had surgery (in-hospital: 19.7% vs. 20.0%, p = 0.4236; 1-year: 27.3% vs. 25.5%, p = 0.7176). Conclusion Although mortality rates are consistently higher in ≥ 80 yo patients than in < 80 yo patients in the general population, mortality of surgery in ≥ 80 yo is similar to < 80 yo after matching patients. These results confirm the importance of a better recognition of surgical indication and of an increased performance of surgery in ≥ 80 yo patients.


  • Age-related characteristics of infective endocarditis: prospective data from the Euro-Endo registry

    by M Pazdernik, C Selton-Suty, P Lancellotti, W.K.F Kong, I Srdanovic, H Yamada, R.K Riezebos, A De Martino, L Pierard, M Nunes, et al.

    Introduction: The profile of infective endocarditis (IE) is continuously evolving over time, and this may probably be partly due to increasing age of the patients. Methods: All data were collected from the EURO-ENDO registry, which is a one-year prospective international multicentre observational survey on patients with definite or possible IE included between 2016 and 2018. Subjects were stratified into 3 groups according to their age at index hospitalization. Results: Among the 3113 patients included, 1670 patients (54%, Young group) were <65, 1068 (34%, Medium group) between 65 and 80 and 375 (12%, Old group) ≥80 years old. The most striking age-related differences were (old group vs others) (table 1) 1) the higher comorbidity burden and Charlson index; 2) the lower rate of embolic events on admission and under therapy; 3) the higher rate of Enterocci and digestive streptococci; 4) the lower rate of surgery during acute IE despite a theoretical indication; 5) the higher in-hospital and 1-year mortality. With regards to surgery, young and medium age were predictive of more frequent performance of surgery as compared to old age (Young: OR 4.33, 95% CI [3.09–6.06], Medium: 3.62, [2.57–5.10], p<0.001). In multivariable analysis, age per se was not predictive of in-hospital and 1yr FU mortality, but lack of surgical procedures when indicated (27% of the old group), was strongly predictive. Conclusion: This is the largest contemporary registry showing the strong influence of age on the demographic, clinical, therapeutic, and prognostic profile of IE. Non-performance of surgical procedures when indicated is frequent in old patients and is a strong predictor of mortality while age per se is not. Endocarditis Teams should take these results into account when considering surgery in elderly patients. Funding Acknowledgement: Type of funding source: Other. Main funding source(s): EORP grant


  • Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis

    by Michal Pazdernik, Helena Bedanova, Zhi Chen, Josef Kautzner, Vojtech Melenovsky, Ivan Malek, Antonij Slavcev, Michaela Bartonova, Vladimir Karmazin, Tomas Eckhardt, et al.


  • Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3‐D optical coherence tomography analysis

    by Michal Pazdernik, Dan Wichterle, Zhi Chen, Helena Bedanova, Josef Kautzner, Vojtech Melenovsky, Vladimir Karmazin, Ivan Malek, Peter Stiavnicky, Ales Tomasek, et al.

    Introduction: Heart rate slowing agents are frequently prescribed to manage heart transplant (HTx) patients with the assumption that higher heart rate is a risk factor in cardiovascular disease.Patients and Methods: This prospective two‐center study investigated early progression of cardiac allograft vasculopathy (CAV) in 116 HTx patients. Examinations by coronary optical coherence tomography and 24‐hour ambulatory ECG monitoring were performed both at baseline (1 month after HTx) and during follow‐up (12 months after HTx).Results: During the first post‐HTx year, we observed a significant reduction in the mean coronary luminal area from 9.0 ± 2.5 to 8.0 ± 2.4 mm2 (P < .001), and progression in mean intimal thickness (IT) from 106.5 ± 40.4 to 130.1 ± 53.0 µm (P < .001). No significant relationship was observed between baseline and follow‐up mean heart rates and IT progression (R = .02, P = .83; R = −.13, P = .18). We found a mild inverse association between beta‐blocker dosage at 12 months and IT progression (R = −.20, P = .035).Conclusion: Our study did not confirm a direct association between mean heart rate and progression of CAV. The role of beta blockers warrants further investigation, with our results indicating that they may play a protective role in early CAV development.